Exopolysaccharide activities from probiotic bifidobacterium: Immunomodulatory effects (on J774A.1 macrophages) and antimicrobial properties

International Journal of Food Microbiology

Volumn 144, Issue 1, 2010, Pages 104-110

  Wu, Ming Hsiu ^a   Pan, Tzu Ming ^b   Wu, Yu Jen ^c   Chang, Sue Joan ^d   Chang, Ming Song ^e   Hu, Chun Yi ^a  

^a FOOYIN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c MEIHO UNIVERSITY   (Taiwan)

^d NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^e Foo Yin Hospital   (Taiwan)

Author keywords

Antimicrobial test; Cytokine; Exopolysaccharide (EPS); Macrophage; Probiotics

Indexed keywords

EXOPOLYSACCHARIDE; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL CELL; BACTERIAL GROWTH; BACTERIAL IMMUNITY; BACTERIAL INFECTION; BACTERIUM CULTURE; BATCH FERMENTATION; BIFIDOBACTERIUM LONGUM; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; FOOD SPOILAGE; GROWTH INHIBITION; HEAT TREATMENT; IMMUNOMODULATION; MACROPHAGE; NONHUMAN;

ANIMALS; ANTI-INFECTIVE AGENTS; BIFIDOBACTERIUM; CELL LINE; CELL PROLIFERATION; GENE EXPRESSION REGULATION; IMMUNOLOGIC FACTORS; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; POLYSACCHARIDES, BACTERIAL; PROBIOTICS; TUMOR NECROSIS FACTOR-ALPHA;

BIFIDOBACTERIUM; BIFIDOBACTERIUM LONGUM;

EID: 78149467574     PISSN: 01681605     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijfoodmicro.2010.09.003     Document Type: Article

References (33)

1. Bamias G., Cominelli F. Novel strategies to attenuate immune activation in Crohn's disease. Current Opinion in Pharmacology 2006, 6:401-407.
2. Beutler B., Cerami A. The biology of cachectin/TNF-a primary mediator of the host response. Annual Review of Immunology 1989, 7:625-655.
3. Chiu H.H., Tsai C.C., Hsih H.Y., Tsen H.Y. Screening from pickled vegetables the potential probiotic strains of lactic acid bacteria able to inhibit the Salmonella invasion in mice. Journal of Applied Microbiology 2008, 104:605-612.
4. Cross M.L., Ganner A., Teilab D., Fray L.M. Patterns of cytokine induction by Gram-positive and Gram-negative probiotic bacteria. FEMS Immunology and Medical Microbiology 2004, 42:173-180.
5. De Man J.C., Rogosa M., Sharpe M.E. A medium for the cultivation of lactobacilli. The Journal of Applied Bacteriology 1960, 23:130-135.
6. De Roos N.M., Katan M.B. Effects of probiotic bacteria on diarrhea, lipid metabolism, and carcinogenesis: a review of papers published between 1988 and 1998. The American Journal of Clinical Nutrition 2000, 71:405-411.
7. De Vuyst L., Degeest B. Heteropolysaccharides from lactic acid bacteria. FEMS Microbiology Reviews 1999, 23:153-177.
8. De Waal Malefyt R., Abrams J., Bennett B., Figdor C.G., Vries J.E. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. The Journal of Experimental Medicine 1991, 174:1209-1220.
9. Dubois M., Gilles K.A., Hamilton J.K., Rebers P.A., Smith F. Colorimetric method for determination of sugars and related substances. Analytical Chemistry 1956, 38:350-356.
10. Erickson K.L., Hubbard N.E. Probiotic immunomodulation in health and disease. The Journal of Nutrition 2000, 130:403S-409S.
11. Forestier C., De Champs C., Vatoux C., Joly B. Probiotic activities of Lactobacillus casei rhamnosus: in vitro adherence to intestinal cells and antimicrobial properties. Research in Microbiology 2001, 152:167-173.
12. Gerard C., Bruyns C., Marchant A., Abramowicz D., Vandenabeele P., Delvaux A., Fiers W., Goldman M., Velu T. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. The Journal of Experimental Medicine 1993, 177:547-550.
13. Ghildyal N., McNeil H.P., Stechschulte S., Austen K.F., Silberstein D., Gurish M.F., Somerville L.L., Stevens R.L. IL-10 induces transcription of the gene for mouse mast cell protease-1, a serine protease preferentially expressed in mucosal mast cells of Trichinella spiralis-infected mice. Journal of Immunology 1992, 149:2123-2129.
14. Go N.F., Castle B.E., Barrett R., Kastelein R., Dang W., Mosmann T.R., Moore K.W., Howard M. Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells. The Journal of Experimental Medicine 1990, 172:1625-1631.
15. Hosono J., Lee A., Amenati M., Natsume M., Hirayama T., Adachi S., Kaminogawa Characterization of a water-soluble polysaccharide fraction with immunopotentiating activity from Bifidobacterium adolescentis M101-4. Bioscience, Biotechnology, and Biochemistry 1997, 61:312-316.
16. Jerala R. Structural biology of the LPS recognition. International Journal of Medical Microbiology 2007, 297:353-363.
17. Kankaanpa P., Sutasb Y., Salminena S., Isolaurib E. Homogenates derived from probiotic bacteria provide downregulatory signals for peripheral blood mononuclear cells. Food Chemistry 2003, 83:269-277.
18. Kitazawa H., Harata T., Uemura J., Saito T., Kaneko T., Itoh T. Phosphate group requirement for mitogenic activation of lymphocytes by an extracellular phosphopolysaccharide from Lactobacillus delbrueckii subsp. bulgaricus. International Journal of Food Microbiology 1998, 40:169-175.
19. Kuhbacher T., Fölsch U.R. Practical guidelines for the treatment of infl ammatory bowel disease. World Journal of Gastroenterology 2007, 13:1149-1155.
20. Marcelletti J.F., Katz D.H. IL-10 stimulates murine antigen-driven antibody responses in vitro by regulating helper cell subset participation. Cell Immunology 1996, 167:86-98.
21. Moore K.W., de Waal Malefyt R., Coffman R.L., O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annual Review of Immunology 2001, 19:683-765.
22. Mpofu C.M., Campbell B.J., Subramanian S., Marshall-Clarke S., Hart C.A., Cross A., Roberts C.L., McGoldrick A., Edwards S.W., Rhodes J.M. Microbial mannan inhibits bacterial killing by macrophages: a possible pathogenic mechanism for Crohn's disease. Gastroenterology 2007, 133:1487-1498.
23. Nishimura-Uemura J., Kitazawa H., Kawai Y., Itoh T., Oda M., Saito T. Functional alteration of murine macrophages stimulated with extracellular polysaccharides from Lactobacillus delbrueckii subsp. bulgaricus OLL1073R-1. Food Microbiology 2003, 20:267-273.
24. Ouwehand A.C., Vesterlund S. Antimicrobial components from lactic acid bacteria. Lactic Acid Bacteria - Microbiological and Functional Aspects 2004, 375-395. Marcel Dekker, Inc., New York. S. Salminen, A. VonWright, A. Ouwehand (Eds.).
25. Ouwehand A.C., Kirjavainen P.V., Shortt C., Salminen S. Probiotics: mechanisms and established effects. International Dairy Journal 1999, 9:43-52.
26. Raetz C.R. Biochemistry of endotoxins. Annual Review of Biochemistry 1990, 59:129-170.
27. Rousset F., Garcia E., Defrance T., Peronne C., Vezzio N., Hsu D.H., Kastelein R., Moore K.W., Banchereau J. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proceedings of the National Academy of Sciences of the United States of America 1992, 89:1890-1893.
28. Serbina N.V., Jia T., Hohl T.M., Pamer E.G. Monocyte-mediated defense against microbial pathogens. Annual Review of Immunology 2008, 26:421-452.
29. Smythies L.E., Sellers M., Clements R.H., Mosteller-Barnum M., Meng G., Benjamin W.H., Orenstein J.M., Smith P.D. Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. The Journal of Clinical Investigation 2005, 115:66-75.
30. Steidler L., Hans W., Schotte L., Neirynck S., Obermeier F., Falk W., Fiers W., Remaut E. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 2000, 289:1352-1355.
31. Whitfield C. Bacterial extracellular polysaccharides. Canadian Journal of Microbiology 1998, 34:415-420.
32. Wilkins B.S., Jones D.B. Contribution of monocyte/macrophage differentiation to the stromal layer in human long-term bone marrow cultures. Biologicals 1996, 24:313-318.
33. Wynn T.A., Cheever A.W., Williams M.E., Hieny S., Caspar P., Kuhn R., Muller W., Sher A. IL-10 regulates liver pathology in acute murine Schistosomiasis mansoni but is not required for immune down-modulation of chronic disease. Journal of Immunology 1998, 160:4473-4480.